webinar register page

Webinar banner
Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials
The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome (APS) remain controversial. In this webinar, we discuss the results of a recent study on DOACs vs Vitamin-K Antagonists (VKAs) in Thrombotic APS which found that patients with thrombotic APS randomized to DOACs appear to have increased risk for arterial thrombosis when compared to VKAs. We will also highlight a recently published AC Forum Rapid Resource on Antiphospholipid Syndrome.

Guest Faculty:
Behnood Bikdeli, MD, MS
Jean Connors, MD
Surabhi Palkimas, PharmD

Geoff Barnes, MD, MSc
Deborah Siegal, MD, MSc, FRCPC

Read the Article:

View the Rapid Resource:

Jan 30, 2023 12:00 PM in Eastern Time (US and Canada)

* Required information